{"id":4399,"date":"2019-08-05T07:17:36","date_gmt":"2019-08-05T07:17:36","guid":{"rendered":"https:\/\/www.gkseries.com\/blog\/?p=4399"},"modified":"2019-08-05T07:17:37","modified_gmt":"2019-08-05T07:17:37","slug":"icmr-launched-2-new-tb-vaccines-vpm-1002-and-immuvac","status":"publish","type":"post","link":"https:\/\/www.gkseries.com\/blog\/icmr-launched-2-new-tb-vaccines-vpm-1002-and-immuvac\/","title":{"rendered":"ICMR launched 2 new TB vaccines, VPM 1002 and Immuvac"},"content":{"rendered":"\n<p>Indian Council of Medical Research (ICMR) has launched a trial for two new TB vaccines. This is the India\u2019s first large-scale trial. This is a large preventive TB vaccine trial. The initiative involves more than twelve thousands healthy household contacts of newly diagnosed TB patients from across six states of India are set to be enrolled.<\/p>\n\n\n\n<p><strong><a href=\"https:\/\/www.gkseries.com\/blog\/current-affairs-quiz-2019-daily-gk\/\" target=\"_blank\" rel=\"noreferrer noopener\">Daily Current Affairs Quiz 2019<\/a><\/strong><\/p>\n\n\n\n<p>Two thousand participants from each of the six states\nincluding Delhi, Maharashtra, Odisha, Telangana and Karnataka will enroll over\nthe next seven to eight months. Also, seven main centres will have six\nsub-sites, where these trials will be conducted.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">The two new vaccines:<\/h4>\n\n\n\n<p>The two new TB vaccines that are introduced by ICMR are:<\/p>\n\n\n\n<p>\u2666\nImmuvac manufactured by Cadila Pharmaceuticals <\/p>\n\n\n\n<p>\u2666 VPM\n1002 manufactured by Institute of India, Pune<\/p>\n\n\n\n<p>The medicines are to be tested with three testing phases.\nBased on the results the Union Ministry of Health and Family Welfare will\ndecide and set the price of the vaccines.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Reason for ICMR&#8217;s new TB vaccines:<\/h4>\n\n\n\n<p>To treat TB multi-drug course that usually spans six months\nis usuallu involved. Scientists from ICMR suggested that new TB vaccines other\nthan BCG (Bacille Calmette-Guerin), which is 100 years old, is needed to treat\nTB as it has been partially effective in protecting infants and young children\nand it provides poor protection against pulmonary disease in adolescents and\nadults.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">About TB in India:<\/h4>\n\n\n\n<p>Data from Ministry of Health and Family Welfare\u2019s Central TB\ndivision said that the TB incidence in India has touched almost 2.8 million\nevery year along with drug-resistant TB incidence at 1,47,000 annually. It also\nsaid that around 27% of the world\u2019s TB incidences are from India. It has marked\nthe highest share at a global level. In 2017, the Centre vowed to eliminate TB\nby the year 2025.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Indian Council of Medical Research (ICMR) has launched a trial for two new TB vaccines. This is the India\u2019s first large-scale trial. This is a large preventive TB vaccine trial. The initiative involves more than twelve thousands healthy household contacts of newly diagnosed TB patients from across six states of India are set to be [&hellip;]<\/p>\n","protected":false},"author":13,"featured_media":4400,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[45],"tags":[359],"class_list":["post-4399","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-current-affairs-articles","tag-icmr"],"_links":{"self":[{"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/posts\/4399","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/comments?post=4399"}],"version-history":[{"count":1,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/posts\/4399\/revisions"}],"predecessor-version":[{"id":4401,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/posts\/4399\/revisions\/4401"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/media\/4400"}],"wp:attachment":[{"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/media?parent=4399"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/categories?post=4399"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/tags?post=4399"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}